Search

everythinglearnresearchcommunity

for

Search:↓

Both HLA-B and MICA are independently linked to alopecia areata.

Apremilast may help treat hair loss in alopecia areata.

Certain genetic markers, especially the MICA gene, are linked to alopecia areata.

ILC1-like cells can cause alopecia areata by disrupting hair follicle immunity, suggesting a new treatment approach.

Transplant success has improved with better immunosuppressive drugs and donor matching.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Certain types of T cells are essential for healthy skin and play a role in skin diseases, but more research is needed to improve treatments.

The document concludes that while there are various treatments for Alopecia Areata, there is no cure, and individualized treatment plans are essential due to varying effectiveness.

Chitosan-decorated polymersomes improve finasteride delivery for hair loss treatment.

Chitosan-coated nanoparticles improve skin delivery of hair loss treatments with fewer side effects.

Scientists made skin stem cells from other human cells with over 97% efficiency, which could help treat skin conditions.

Special nanoparticles increased skin absorption of hair loss treatments with fewer side effects.

Gamma delta T cells in the skin help with healing and defense but can also cause autoimmune issues, and more research is needed to understand how they are activated.

New protein changes may be involved in the immune attack on hair follicles in alopecia areata.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Melanocytes are important for skin and hair color and protect the skin from UV damage.

Researchers found four genes that could help diagnose severe alopecia areata early.

The document suggests creating a secure database for indigenous knowledge and recommends that the TKDL actively fight patents that slightly alter traditional knowledge.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.

ILC1-like cells can cause alopecia areata by attacking hair follicles.

Zinc is essential for plant growth and human health, but many soils lack enough zinc, affecting crops and potentially leading to health problems.

Botulinum toxin type A significantly reduces scalp psoriasis severity compared to placebo.

Terbinafine is more effective than itraconazole for toenail fungus, especially in older patients, and debridement improves its effectiveness.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

HLA-DRB5 and other genes may be linked to alopecia universalis.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

New treatments for hair loss from alopecia areata may include targeting immune cells, using stem cells, balancing gut bacteria, applying fatty acids, and using JAK inhibitors.

Certain genes on chromosomes 6, 10, 16, and 18 may increase the risk of alopecia areata.